Concepts (308)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nicotine | 27 | 2018 | 194 | 5.470 |
Why?
|
| Nicotinic Agonists | 16 | 2017 | 72 | 3.450 |
Why?
|
| Receptors, Nicotinic | 27 | 2017 | 129 | 3.410 |
Why?
|
| Dopamine | 18 | 2016 | 275 | 2.230 |
Why?
|
| Ventral Tegmental Area | 11 | 2013 | 43 | 2.220 |
Why?
|
| Synapses | 12 | 2018 | 265 | 1.390 |
Why?
|
| Long-Term Potentiation | 7 | 2014 | 47 | 1.250 |
Why?
|
| Nucleus Accumbens | 7 | 2017 | 113 | 1.250 |
Why?
|
| Synaptic Transmission | 13 | 2017 | 222 | 1.220 |
Why?
|
| Rats, Sprague-Dawley | 21 | 2017 | 1219 | 1.210 |
Why?
|
| Central Nervous System Depressants | 2 | 2016 | 45 | 1.110 |
Why?
|
| Reward | 5 | 2018 | 181 | 1.040 |
Why?
|
| Excitatory Postsynaptic Potentials | 7 | 2017 | 87 | 0.960 |
Why?
|
| Neurons | 12 | 2016 | 1546 | 0.960 |
Why?
|
| Ethanol | 2 | 2016 | 249 | 0.950 |
Why?
|
| Neuronal Plasticity | 5 | 2014 | 187 | 0.910 |
Why?
|
| Rats | 22 | 2017 | 3990 | 0.900 |
Why?
|
| Glutamic Acid | 9 | 2016 | 152 | 0.850 |
Why?
|
| Tobacco Use Disorder | 4 | 2009 | 108 | 0.820 |
Why?
|
| Analgesics | 3 | 2017 | 119 | 0.810 |
Why?
|
| Animals | 56 | 2018 | 26582 | 0.780 |
Why?
|
| Cholinergic Agents | 3 | 2017 | 17 | 0.770 |
Why?
|
| Corpus Striatum | 3 | 2016 | 86 | 0.760 |
Why?
|
| Action Potentials | 10 | 2015 | 573 | 0.740 |
Why?
|
| Raphe Nuclei | 2 | 2011 | 37 | 0.690 |
Why?
|
| GABAergic Neurons | 2 | 2018 | 16 | 0.680 |
Why?
|
| Habenula | 2 | 2018 | 2 | 0.680 |
Why?
|
| Neural Pathways | 2 | 2018 | 308 | 0.680 |
Why?
|
| Interpeduncular Nucleus | 1 | 2018 | 1 | 0.670 |
Why?
|
| Tegmentum Mesencephali | 1 | 2018 | 12 | 0.670 |
Why?
|
| Avoidance Learning | 1 | 2018 | 16 | 0.660 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 4 | 2016 | 21 | 0.650 |
Why?
|
| Neurons, Afferent | 5 | 2014 | 79 | 0.640 |
Why?
|
| Stress, Physiological | 3 | 2009 | 227 | 0.630 |
Why?
|
| Periaqueductal Gray | 1 | 2017 | 10 | 0.630 |
Why?
|
| Receptors, Opioid | 2 | 2008 | 24 | 0.610 |
Why?
|
| In Vitro Techniques | 10 | 2016 | 989 | 0.590 |
Why?
|
| Medulla Oblongata | 1 | 2017 | 89 | 0.590 |
Why?
|
| Motor Disorders | 1 | 2016 | 7 | 0.580 |
Why?
|
| Dopaminergic Neurons | 3 | 2016 | 25 | 0.570 |
Why?
|
| Hippocampus | 3 | 2009 | 442 | 0.550 |
Why?
|
| Ganglia, Spinal | 6 | 2003 | 72 | 0.540 |
Why?
|
| Motor Activity | 4 | 2016 | 327 | 0.510 |
Why?
|
| Inhibitory Postsynaptic Potentials | 2 | 2012 | 20 | 0.510 |
Why?
|
| Patch-Clamp Techniques | 11 | 2014 | 396 | 0.490 |
Why?
|
| Behavior, Animal | 4 | 2012 | 373 | 0.470 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 267 | 0.470 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 3 | 2017 | 76 | 0.450 |
Why?
|
| Receptors, AMPA | 5 | 2017 | 66 | 0.450 |
Why?
|
| Acetylcholine | 6 | 2017 | 176 | 0.440 |
Why?
|
| Brain | 5 | 2012 | 2216 | 0.440 |
Why?
|
| Substantia Nigra | 2 | 2013 | 27 | 0.430 |
Why?
|
| Behavior | 2 | 2009 | 85 | 0.410 |
Why?
|
| Serotonergic Neurons | 1 | 2011 | 4 | 0.410 |
Why?
|
| Cholinesterase Inhibitors | 3 | 2002 | 45 | 0.390 |
Why?
|
| Receptors, Presynaptic | 2 | 2008 | 4 | 0.370 |
Why?
|
| Receptors, GABA | 2 | 2012 | 10 | 0.370 |
Why?
|
| Cholinergic Fibers | 2 | 2010 | 23 | 0.340 |
Why?
|
| Electrophysiology | 8 | 2011 | 401 | 0.330 |
Why?
|
| gamma-Aminobutyric Acid | 6 | 2007 | 83 | 0.330 |
Why?
|
| Learning | 4 | 2016 | 280 | 0.330 |
Why?
|
| Presynaptic Terminals | 3 | 2000 | 40 | 0.320 |
Why?
|
| Nicotinic Antagonists | 1 | 2007 | 3 | 0.310 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2007 | 8 | 0.310 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 1 | 2007 | 4 | 0.310 |
Why?
|
| Bupropion | 1 | 2007 | 21 | 0.310 |
Why?
|
| Receptors, GABA-B | 1 | 2007 | 7 | 0.310 |
Why?
|
| Parkinson Disease | 3 | 2015 | 132 | 0.300 |
Why?
|
| Memory | 2 | 2002 | 225 | 0.300 |
Why?
|
| Fluoxetine | 1 | 2007 | 42 | 0.300 |
Why?
|
| Receptor Cross-Talk | 1 | 2006 | 33 | 0.290 |
Why?
|
| Substance-Related Disorders | 3 | 2009 | 394 | 0.290 |
Why?
|
| Mice | 15 | 2018 | 11352 | 0.270 |
Why?
|
| Receptors, Glycine | 2 | 2005 | 10 | 0.270 |
Why?
|
| Receptors, Dopamine D2 | 3 | 2016 | 57 | 0.270 |
Why?
|
| Male | 17 | 2018 | 40965 | 0.270 |
Why?
|
| Pyridines | 2 | 2005 | 310 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 8 | 2018 | 3092 | 0.260 |
Why?
|
| Posterior Horn Cells | 1 | 2005 | 8 | 0.260 |
Why?
|
| Gene Expression Regulation | 5 | 2017 | 1920 | 0.260 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2005 | 12 | 0.260 |
Why?
|
| Cyclic AMP | 2 | 2016 | 273 | 0.250 |
Why?
|
| Excitatory Amino Acid Antagonists | 3 | 2016 | 78 | 0.240 |
Why?
|
| Quinoxalines | 3 | 2016 | 50 | 0.240 |
Why?
|
| Receptors, Opioid, mu | 2 | 2017 | 45 | 0.230 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2016 | 1961 | 0.230 |
Why?
|
| Gene Expression | 4 | 2018 | 1284 | 0.210 |
Why?
|
| Aconitine | 1 | 2001 | 3 | 0.210 |
Why?
|
| Organ Culture Techniques | 4 | 2012 | 135 | 0.210 |
Why?
|
| Solanine | 1 | 2000 | 1 | 0.190 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 1 | 2000 | 14 | 0.190 |
Why?
|
| Isoquinolines | 1 | 2000 | 72 | 0.190 |
Why?
|
| Synaptic Potentials | 2 | 2016 | 15 | 0.180 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2011 | 87 | 0.180 |
Why?
|
| Tissue Culture Techniques | 2 | 2017 | 79 | 0.180 |
Why?
|
| Drug Tolerance | 2 | 2016 | 63 | 0.170 |
Why?
|
| Analgesics, Opioid | 2 | 2017 | 413 | 0.170 |
Why?
|
| Calcium | 8 | 2007 | 1156 | 0.170 |
Why?
|
| Phosphorylation | 3 | 2017 | 1106 | 0.170 |
Why?
|
| Neurotransmitter Agents | 2 | 2016 | 106 | 0.170 |
Why?
|
| Channelrhodopsins | 1 | 2018 | 7 | 0.170 |
Why?
|
| Hormone Antagonists | 2 | 2009 | 20 | 0.160 |
Why?
|
| Mifepristone | 2 | 2009 | 33 | 0.160 |
Why?
|
| Optogenetics | 1 | 2018 | 30 | 0.160 |
Why?
|
| Electric Stimulation | 4 | 2014 | 347 | 0.160 |
Why?
|
| Stereotaxic Techniques | 1 | 2018 | 69 | 0.160 |
Why?
|
| Transgenes | 1 | 2018 | 180 | 0.160 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2017 | 22 | 0.160 |
Why?
|
| Quinuclidines | 1 | 2017 | 26 | 0.150 |
Why?
|
| Solanaceous Alkaloids | 1 | 1997 | 1 | 0.150 |
Why?
|
| Electrodes, Implanted | 1 | 2018 | 171 | 0.150 |
Why?
|
| Cells, Cultured | 5 | 2007 | 2818 | 0.150 |
Why?
|
| Calcium-Binding Proteins | 1 | 1997 | 115 | 0.150 |
Why?
|
| Enkephalins | 1 | 2016 | 16 | 0.150 |
Why?
|
| Cholinesterases | 1 | 2016 | 17 | 0.150 |
Why?
|
| Immunohistochemistry | 3 | 2011 | 1753 | 0.140 |
Why?
|
| Self Administration | 1 | 2016 | 73 | 0.140 |
Why?
|
| Isoxazoles | 1 | 2016 | 77 | 0.140 |
Why?
|
| Kidney | 2 | 2001 | 1241 | 0.140 |
Why?
|
| Pain Measurement | 1 | 2017 | 321 | 0.140 |
Why?
|
| Amphetamine | 1 | 2017 | 101 | 0.140 |
Why?
|
| Phenylurea Compounds | 1 | 2016 | 114 | 0.140 |
Why?
|
| Interneurons | 3 | 2015 | 93 | 0.140 |
Why?
|
| Bradykinin | 2 | 1992 | 46 | 0.140 |
Why?
|
| Thyroid Gland | 1 | 1997 | 270 | 0.140 |
Why?
|
| Lysine | 1 | 2016 | 147 | 0.130 |
Why?
|
| Receptors, Glutamate | 2 | 2007 | 24 | 0.130 |
Why?
|
| Receptors, Histamine H2 | 1 | 2015 | 5 | 0.130 |
Why?
|
| Cholinergic Neurons | 1 | 2015 | 8 | 0.130 |
Why?
|
| Ion Channel Gating | 5 | 1999 | 324 | 0.130 |
Why?
|
| Pyramidal Cells | 3 | 2007 | 80 | 0.130 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 2015 | 19 | 0.130 |
Why?
|
| Levodopa | 2 | 2015 | 36 | 0.130 |
Why?
|
| Thyroid Hormones | 1 | 1997 | 321 | 0.130 |
Why?
|
| Receptors, Cell Surface | 1 | 1996 | 286 | 0.130 |
Why?
|
| Miniature Postsynaptic Potentials | 2 | 2017 | 6 | 0.130 |
Why?
|
| Globus Pallidus | 1 | 2014 | 17 | 0.120 |
Why?
|
| Neostriatum | 1 | 2014 | 26 | 0.120 |
Why?
|
| Central Nervous System Stimulants | 1 | 2017 | 216 | 0.120 |
Why?
|
| Cell Membrane | 1 | 2017 | 666 | 0.120 |
Why?
|
| Humans | 16 | 2013 | 86643 | 0.120 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 639 | 0.110 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2012 | 14 | 0.110 |
Why?
|
| Tunicamycin | 1 | 2012 | 12 | 0.110 |
Why?
|
| Cyclic GMP | 1 | 1992 | 58 | 0.110 |
Why?
|
| Smoking | 3 | 2002 | 609 | 0.110 |
Why?
|
| Inclusion Bodies | 1 | 2012 | 34 | 0.110 |
Why?
|
| Insecticides | 2 | 2002 | 27 | 0.100 |
Why?
|
| Membrane Potentials | 2 | 2007 | 435 | 0.100 |
Why?
|
| Locomotion | 1 | 2013 | 131 | 0.100 |
Why?
|
| Dyskinesias | 1 | 2010 | 7 | 0.100 |
Why?
|
| Bungarotoxins | 3 | 2001 | 25 | 0.100 |
Why?
|
| Nitric Oxide | 1 | 1992 | 278 | 0.100 |
Why?
|
| Pain | 1 | 2013 | 391 | 0.100 |
Why?
|
| Animals, Newborn | 3 | 2012 | 510 | 0.100 |
Why?
|
| Dentate Gyrus | 1 | 2009 | 32 | 0.090 |
Why?
|
| Chick Embryo | 3 | 2000 | 229 | 0.090 |
Why?
|
| Adenylyl Cyclases | 1 | 2009 | 100 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2011 | 912 | 0.080 |
Why?
|
| Time Factors | 2 | 2016 | 5210 | 0.080 |
Why?
|
| Isoenzymes | 1 | 2009 | 271 | 0.080 |
Why?
|
| Receptors, sigma | 1 | 2008 | 6 | 0.080 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2008 | 38 | 0.080 |
Why?
|
| Choline | 1 | 2007 | 23 | 0.080 |
Why?
|
| Substance P | 1 | 2008 | 61 | 0.080 |
Why?
|
| Urinary Bladder Diseases | 1 | 2008 | 41 | 0.080 |
Why?
|
| Neuromuscular Agents | 1 | 2008 | 25 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2012 | 3241 | 0.080 |
Why?
|
| Bicuculline | 1 | 2007 | 18 | 0.080 |
Why?
|
| Pyrrolidines | 1 | 2008 | 58 | 0.080 |
Why?
|
| Corticosterone | 1 | 2007 | 35 | 0.080 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2008 | 49 | 0.080 |
Why?
|
| Age Factors | 1 | 2012 | 1851 | 0.080 |
Why?
|
| Mice, Transgenic | 4 | 2014 | 1540 | 0.080 |
Why?
|
| Protein Subunits | 1 | 2006 | 122 | 0.070 |
Why?
|
| Statistics as Topic | 1 | 2007 | 238 | 0.070 |
Why?
|
| Piperidines | 1 | 2008 | 181 | 0.070 |
Why?
|
| Cloning, Molecular | 2 | 1999 | 646 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 1208 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 297 | 0.070 |
Why?
|
| Urinary Bladder | 1 | 2008 | 246 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2009 | 584 | 0.070 |
Why?
|
| Pyramidal Tracts | 1 | 2004 | 16 | 0.060 |
Why?
|
| Motor Cortex | 1 | 2007 | 195 | 0.060 |
Why?
|
| Neural Inhibition | 1 | 2005 | 97 | 0.060 |
Why?
|
| Staining and Labeling | 1 | 2004 | 165 | 0.060 |
Why?
|
| Lumbar Vertebrae | 1 | 2005 | 148 | 0.060 |
Why?
|
| Spinal Cord | 1 | 2005 | 249 | 0.060 |
Why?
|
| Fluorescent Dyes | 1 | 2004 | 242 | 0.060 |
Why?
|
| Molecular Sequence Data | 3 | 1999 | 3030 | 0.050 |
Why?
|
| Transfection | 2 | 2001 | 896 | 0.050 |
Why?
|
| Ganglionic Stimulants | 1 | 2002 | 7 | 0.050 |
Why?
|
| Organothiophosphorus Compounds | 1 | 2002 | 17 | 0.050 |
Why?
|
| Acetylcholinesterase | 1 | 2002 | 47 | 0.050 |
Why?
|
| Atropine | 1 | 2002 | 59 | 0.050 |
Why?
|
| Cholinergic Antagonists | 1 | 2002 | 26 | 0.050 |
Why?
|
| Quinolizines | 1 | 2001 | 6 | 0.050 |
Why?
|
| Azocines | 1 | 2001 | 3 | 0.050 |
Why?
|
| Alkaloids | 1 | 2001 | 45 | 0.050 |
Why?
|
| Muscarinic Antagonists | 1 | 2002 | 55 | 0.050 |
Why?
|
| Cell Size | 1 | 2001 | 65 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2001 | 1981 | 0.050 |
Why?
|
| Vasodilator Agents | 1 | 2001 | 152 | 0.050 |
Why?
|
| Solanum tuberosum | 1 | 2000 | 3 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2001 | 393 | 0.050 |
Why?
|
| DNA Primers | 1 | 2001 | 543 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2000 | 248 | 0.050 |
Why?
|
| Rabbits | 1 | 2000 | 636 | 0.040 |
Why?
|
| Disulfides | 1 | 1999 | 64 | 0.040 |
Why?
|
| Mutagenesis | 1 | 1999 | 199 | 0.040 |
Why?
|
| Amino Acid Sequence | 3 | 1999 | 2062 | 0.040 |
Why?
|
| Cell Communication | 1 | 1999 | 194 | 0.040 |
Why?
|
| Nimodipine | 1 | 1997 | 11 | 0.040 |
Why?
|
| Type C Phospholipases | 1 | 1997 | 28 | 0.040 |
Why?
|
| Butyrylcholinesterase | 1 | 1997 | 10 | 0.040 |
Why?
|
| Electric Conductivity | 2 | 1999 | 144 | 0.040 |
Why?
|
| Post-Synaptic Density | 1 | 2017 | 7 | 0.040 |
Why?
|
| Sheep | 1 | 1997 | 239 | 0.040 |
Why?
|
| Gadolinium | 1 | 1997 | 103 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 1997 | 146 | 0.040 |
Why?
|
| Binding Sites | 2 | 1999 | 1098 | 0.040 |
Why?
|
| Magnesium | 1 | 1997 | 177 | 0.040 |
Why?
|
| Periodicity | 1 | 1997 | 119 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 107 | 0.040 |
Why?
|
| Biological Transport | 1 | 1997 | 396 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 1997 | 203 | 0.040 |
Why?
|
| Glutamine | 1 | 1996 | 76 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 1997 | 270 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 2232 | 0.030 |
Why?
|
| Ganglia, Sympathetic | 1 | 1995 | 8 | 0.030 |
Why?
|
| Serotonin | 1 | 1997 | 218 | 0.030 |
Why?
|
| Culture Techniques | 1 | 1995 | 91 | 0.030 |
Why?
|
| Thalamic Nuclei | 1 | 1995 | 32 | 0.030 |
Why?
|
| Dicyclomine | 1 | 2015 | 3 | 0.030 |
Why?
|
| Famotidine | 1 | 2015 | 3 | 0.030 |
Why?
|
| Histamine H2 Antagonists | 1 | 2015 | 15 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2014 | 49 | 0.030 |
Why?
|
| Female | 6 | 2016 | 44532 | 0.030 |
Why?
|
| Exocytosis | 1 | 2013 | 108 | 0.030 |
Why?
|
| Central Nervous System Sensitization | 1 | 2013 | 10 | 0.030 |
Why?
|
| Dopamine D2 Receptor Antagonists | 1 | 2012 | 7 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 1995 | 736 | 0.030 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1992 | 13 | 0.030 |
Why?
|
| Nitroarginine | 1 | 1992 | 16 | 0.030 |
Why?
|
| omega-N-Methylarginine | 1 | 1992 | 17 | 0.030 |
Why?
|
| Nitroprusside | 1 | 1992 | 32 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1992 | 145 | 0.030 |
Why?
|
| TDP-43 Proteinopathies | 1 | 2012 | 8 | 0.030 |
Why?
|
| Hybridomas | 1 | 1992 | 74 | 0.030 |
Why?
|
| Arginine | 1 | 1992 | 136 | 0.030 |
Why?
|
| Drug Synergism | 1 | 1992 | 303 | 0.030 |
Why?
|
| Base Sequence | 1 | 1995 | 2330 | 0.030 |
Why?
|
| Aminoacetonitrile | 1 | 2010 | 3 | 0.020 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2010 | 23 | 0.020 |
Why?
|
| Aphakia | 1 | 2010 | 10 | 0.020 |
Why?
|
| Adenosine A2 Receptor Antagonists | 1 | 2010 | 13 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 411 | 0.020 |
Why?
|
| Cholecystokinin | 1 | 1990 | 15 | 0.020 |
Why?
|
| Adenosine | 1 | 2012 | 225 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 712 | 0.020 |
Why?
|
| Rotarod Performance Test | 1 | 2009 | 9 | 0.020 |
Why?
|
| Potassium Channels | 1 | 1992 | 340 | 0.020 |
Why?
|
| Adolescent | 1 | 2002 | 8981 | 0.020 |
Why?
|
| Reaction Time | 1 | 2009 | 309 | 0.020 |
Why?
|
| Urodynamics | 1 | 2008 | 122 | 0.020 |
Why?
|
| Riluzole | 1 | 2007 | 15 | 0.020 |
Why?
|
| Malonates | 1 | 2007 | 11 | 0.020 |
Why?
|
| N-Methylaspartate | 1 | 2007 | 51 | 0.020 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2007 | 45 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2010 | 536 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 746 | 0.020 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2006 | 35 | 0.020 |
Why?
|
| Neuroprotective Agents | 1 | 2007 | 94 | 0.020 |
Why?
|
| Cell Death | 1 | 2007 | 256 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2006 | 782 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2009 | 1924 | 0.020 |
Why?
|
| Axonal Transport | 1 | 2004 | 31 | 0.020 |
Why?
|
| Benzoates | 1 | 2004 | 44 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2004 | 140 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2010 | 1565 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 425 | 0.010 |
Why?
|
| Cell Survival | 1 | 2004 | 969 | 0.010 |
Why?
|
| Cell Line | 2 | 1999 | 2468 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2000 | 69 | 0.010 |
Why?
|
| Olfactory Bulb | 1 | 2000 | 40 | 0.010 |
Why?
|
| Mesencephalon | 1 | 2000 | 64 | 0.010 |
Why?
|
| Ethylmaleimide | 1 | 1999 | 11 | 0.010 |
Why?
|
| Receptors, Serotonin | 1 | 1999 | 34 | 0.010 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 1 | 1999 | 15 | 0.010 |
Why?
|
| Receptors, Cholinergic | 1 | 1999 | 76 | 0.010 |
Why?
|
| Chickens | 1 | 1999 | 212 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1999 | 121 | 0.010 |
Why?
|
| Sympathetic Nervous System | 1 | 1999 | 104 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1999 | 373 | 0.010 |
Why?
|
| Ion Channels | 1 | 1999 | 246 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1999 | 557 | 0.010 |
Why?
|
| Protein Folding | 1 | 1999 | 282 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1999 | 371 | 0.010 |
Why?
|
| Kinetics | 1 | 1999 | 1513 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1999 | 881 | 0.010 |
Why?
|
| Heart | 1 | 1999 | 539 | 0.010 |
Why?
|
| Pregnancy | 1 | 2000 | 2894 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1999 | 1196 | 0.010 |
Why?
|
| Mathematics | 1 | 1992 | 190 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1990 | 171 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1990 | 245 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 312 | 0.010 |
Why?
|
| Species Specificity | 1 | 1990 | 678 | 0.000 |
Why?
|